EndPath Radiotherapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
EndPath Radiotherapeutics General Information
Description
Operator of a pharmaceutical company intended to develop radiopharmaceuticals for cancer diagnosis and treatment. The company is currently operating in Stealth mode.
Contact Information
Corporate Office
- 1001 Page Mill Road
- Suite 200B, Building 4
- Palo Alto, CA 94304-1007
- United States
Corporate Office
- 1001 Page Mill Road
- Suite 200B, Building 4
- Palo Alto, CA 94304-1007
- United States
EndPath Radiotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Aug-2026 | Completed | Stealth |
EndPath Radiotherapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
EndPath Radiotherapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| venBio | Venture Capital | Minority |
EndPath Radiotherapeutics FAQs
-
Where is EndPath Radiotherapeutics headquartered?
EndPath Radiotherapeutics is headquartered in Palo Alto, CA.
-
What industry is EndPath Radiotherapeutics in?
EndPath Radiotherapeutics’s primary industry is Drug Discovery.
-
Is EndPath Radiotherapeutics a private or public company?
EndPath Radiotherapeutics is a Private company.
-
What is EndPath Radiotherapeutics’s current revenue?
The current revenue for EndPath Radiotherapeutics is .
-
Who are EndPath Radiotherapeutics’s investors?
venBio has invested in EndPath Radiotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
